BCIQ Profiles

Company Profile Report
0322 MgTrax
BioCentury & Getty Images

Management Tracks 

Brainard to succeed Hallal as AlloVir CEO; plus Illumina, NeoGenomics, Nordic Nanovector, Abeona, Delix and more

Mar 23, 2021 | 1:44 AM GMT

Diana Brainard will become CEO of AlloVir Inc. (NASDAQ:ALVR), succeeding David Hallal who will become executive chairman. Brainard is SVP and head of the virology therapeutic area at Gilead Sciences Inc.

Read the full 540 word article

How to gain access

Continue reading with a
two-week free trial.